Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma

Cai,Lisheng; Ma,Xudong; Huang,Yiqun; Zou,Yong; Chen,Xingsheng

doi:10.3892/or.2014.3135

Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma

Authors:
- Lisheng Cai
- Xudong Ma
- Yiqun Huang
- Yong Zou
- Xingsheng Chen
View Affiliations

Affiliations: Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian 363000, P.R. China, United Hospital of Fujian Medical University, Fuzhou, Fujian 350001, P.R. China
Published online on: April 14, 2014 https://doi.org/10.3892/or.2014.3135
Pages: 2593-2600

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the involvement of the Suv39H1 histone methyltransferase in the epigenetic changes in the euchromatic promoter in gastric carcinoma. We retrospectively analyzed the protein of Suv39H1 and tri-methylated histone H3 lysine 9 (H3K9) and histone H3 lysine 4 (H3K4) in 175 cases of gastric carcinoma by immunohistochemistry. Suv39H1 was depleted by siRNA, and cell apoptosis and cell proliferation were assessed by TUNEL and MTT assays, respectively. Histone methylated H3K9 and histone acetylated H3 and H4 were evaluated by western blotting. We found that the expression of Suv39H1 and tri-methylated H3K9 in gastric carcinoma was higher than that in benign gastric diseases (p<0.05). Tri-methylated H3K4 was similar in both tissue types (p>0.05). Both Suv39H1 and tri-methylated H3K9 were positively correlated with the degree of differentiation, depth of infiltration and lymphatic invasion (p<0.05) in gastric carcinoma. In addition, tri-methylated H3K9 was positively correlated with tumor stage, and node and metastatic statuses (p<0.05). Activation of Suv39H1 and overexpression of H3K9 tri-methylation may play an important role in tumorigenesis. They may be useful as a predictor for poor prognosis in gastric carcinoma. Silencing of the Suv39H1 gene decreased tri-methylated H3K9 and increased histone H3 acetylation, which caused activation of gene transcription, while there was no change in histone H4 acetylation. Depletion of Suv39H1 induced apoptosis and inhibited cell proliferation in the gastric cancer MGC803 cell line, while decreasing BCL-2, pro-caspase-9, pro-caspase-3 and C-myc. Suv39H1 may be a potential gene target for anti-gastric carcinoma therapy.

View Figures

View References

1	Jenuwein T and Allis CD: Translating the histone code. Science. 293:1074–1080. 2001. View Article : Google Scholar : PubMed/NCBI
2	Fischle W, Wang Y and Allis CD: Histone and chromatin cross-talk. Curr Opin Cell Biol. 15:172–183. 2003. View Article : Google Scholar : PubMed/NCBI
3	Lachner M, O’Sullivan RJ and Jenuwein T: An epigenetic road map for histone lysine methylation. J Cell Sci. 116:2117–2124. 2003. View Article : Google Scholar : PubMed/NCBI
4	Klose RJ, Kallin EM and Zhang Y: JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 7:715–727. 2006. View Article : Google Scholar : PubMed/NCBI
5	Cang S, Ma Y and Liu D: New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer. J Hematol Oncol. 2:222009. View Article : Google Scholar : PubMed/NCBI
6	Tan J, Cang S, Ma Y, Petrillo RL and Liu D: Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol. 3:52010. View Article : Google Scholar : PubMed/NCBI
7	Rea S, Eisenhaber F, O’Carroll D, et al: Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 406:593–599. 2000. View Article : Google Scholar : PubMed/NCBI
8	Allshire RC, Nimmo ER, Ekwall K, Javerzat JP and Cranston G: Mutations derepressing silent centromeric domains in fission yeast disrupt chromosome segregation. Genes Dev. 9:218–233. 1995. View Article : Google Scholar : PubMed/NCBI
9	Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G and Reuter G: The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3–9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J. 13:3822–3831. 1994.
10	Aagaard L, Laible G, Selenko P, et al: Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3–9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 18:1923–1938. 1999.PubMed/NCBI
11	Peters AH, Kubicek S, Mechtler K, et al: Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell. 12:1577–1589. 2003. View Article : Google Scholar : PubMed/NCBI
12	Di Croce L, Raker VA, Corsaro M, et al: Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 295:1079–1082. 2002.PubMed/NCBI
13	Nielsen SJ, Schneider R, Bauer UM, et al: Rb targets histone H3 methylation and HP1 to promoters. Nature. 412:561–565. 2001. View Article : Google Scholar : PubMed/NCBI
14	Varambally S, Dhanasekaran SM, Zhou M, et al: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 419:624–629. 2002. View Article : Google Scholar : PubMed/NCBI
15	Milne TA, Briggs SD, Brock HW, et al: MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 10:1107–1117. 2002. View Article : Google Scholar : PubMed/NCBI
16	Chakraborty S, Sinha KK, Senyuk V and Nucifora G: SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo. Oncogene. 22:1107–1117. 2003. View Article : Google Scholar : PubMed/NCBI
17	Ma X, Fang Y, Beklemisheva A, et al: Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells. Int J Oncol. 28:1287–1293. 2006.PubMed/NCBI
18	Kang MY, Lee BB, Kim YH, et al: Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer. 121:2192–2197. 2007. View Article : Google Scholar : PubMed/NCBI
19	Zou Y, Ma X, Huang Y, Hong L and Chiao JW: Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. J Hematol Oncol. 5:362012. View Article : Google Scholar : PubMed/NCBI
20	Park YS, Jin MY, Kim YJ, Yook JH, Kim BS and Jang SJ: The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 15:1968–1976. 2008. View Article : Google Scholar : PubMed/NCBI
21	Ozdağ H, Teschendorff AE, Ahmed AA, et al: Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics. 7:902006.PubMed/NCBI
22	Pogribny IP, Ross SA, Tryndyak VP, Pogribna M, Poirier LA and Karpinets TV: Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis. 27:1180–1186. 2006. View Article : Google Scholar : PubMed/NCBI
23	Williams L and Grafi G: The retinoblastoma protein - a bridge to heterochromatin. Trends Plant Sci. 5:239–240. 2000. View Article : Google Scholar : PubMed/NCBI
24	Dunaief JL, Strober BE, Guha S, et al: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 79:119–130. 1994. View Article : Google Scholar : PubMed/NCBI
25	Trouche D, Le Chalony C, Muchardt C, Yaniv M and Kouzarides T: RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA. 94:11268–11273. 1997. View Article : Google Scholar : PubMed/NCBI
26	Cheng M, Olivier P, Diehl JA, et al: The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583. 1999.
27	Czvitkovich S, Sauer S, Peters AH, et al: Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech Dev. 107:141–153. 2001. View Article : Google Scholar : PubMed/NCBI
28	Ait-Si-Ali S, Guasconi V, Fritsch L, et al: A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23:605–615. 2004.PubMed/NCBI
29	Tamaru H and Selker EU: A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature. 414:277–283. 2001. View Article : Google Scholar : PubMed/NCBI
30	Jackson JP, Lindroth AM, Cao X and Jacobsen SE: Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature. 416:556–560. 2002. View Article : Google Scholar : PubMed/NCBI
31	Lehnertz B, Ueda Y, Derijck AA, et al: Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 13:1192–1200. 2003. View Article : Google Scholar
32	Czermin B, Schotta G, Hülsmann BB, et al: Physical and functional association of SU(VAR)3–9 and HDAC1 in Drosophila. EMBO Rep. 2:915–919. 2001.PubMed/NCBI
33	Vaute O, Nicolas E, Vandel L and Trouche D: Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Res. 30:475–481. 2002. View Article : Google Scholar : PubMed/NCBI
34	Lachner M and Jenuwein T: The many faces of histone lysine methylation. Curr Opin Cell Biol. 14:286–298. 2002. View Article : Google Scholar : PubMed/NCBI